These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21839737)

  • 1. Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro.
    Bauer S; Weiss TS; Wiest R; Schacherer D; Hellerbrand C; Farkas S; Scherer MN; Ritter M; Schmitz G; Schäffler A; Buechler C
    Exp Mol Pathol; 2011 Dec; 91(3):733-9. PubMed ID: 21839737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte CD163 is altered in association with diabetic complications: possible protective role.
    Min D; Brooks B; Wong J; Aamidor S; Seehoo R; Sutanto S; Harrisberg B; Yue DK; Twigg SM; McLennan SV
    J Leukoc Biol; 2016 Dec; 100(6):1375-1383. PubMed ID: 27354410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
    Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
    Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
    J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated soluble CD163 plasma levels are associated with disease severity in patients with hemorrhagic fever with renal syndrome.
    Wang J; Guo W; Du H; Yu H; Jiang W; Zhu T; Bai X; Wang P
    PLoS One; 2014; 9(11):e112127. PubMed ID: 25392926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD163 Levels and CD163+CD14+ Monocyte/Macrophage Counts in Patients with Asthma.
    Zhi Y; Gao P; Li W; Gao F; Zhang J; Lin H; Zhang J
    Iran J Immunol; 2018 Sep; 15(3):239-245. PubMed ID: 30246699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin induces monocyte recruitment and CD163-macrophage polarization in abdominal aortic aneurysm.
    Rubio-Navarro A; Amaro Villalobos JM; Lindholt JS; Buendía I; Egido J; Blanco-Colio LM; Samaniego R; Meilhac O; Michel JB; Martín-Ventura JL; Moreno JA
    Int J Cardiol; 2015 Dec; 201():66-78. PubMed ID: 26296046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients.
    Tanimura H; Mizuno K; Okamoto H
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):99-105. PubMed ID: 26278688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of CD163 in monocytes and its soluble form in the plasma is associated with a pro-inflammatory profile in pregnant women with preeclampsia.
    Nunes PR; Romão-Veiga M; Peraçoli JC; Araujo Costa RA; de Oliveira LG; Borges VTM; Peraçoli MT
    Immunol Res; 2019 Jun; 67(2-3):194-201. PubMed ID: 31240481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multiparameter Flow Cytometry Analysis Panel to Assess CD163 mRNA and Protein in Monocyte and Macrophage Populations in Hyperinflammatory Diseases.
    Thornton S; Tan R; Sproles A; Do T; Schick J; Grom AA; DeLay M; Schulert GS
    J Immunol; 2019 Mar; 202(5):1635-1643. PubMed ID: 30683706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
    Tornai T; Vitalis Z; Sipeki N; Dinya T; Tornai D; Antal-Szalmas P; Karanyi Z; Tornai I; Papp M
    Liver Int; 2016 Nov; 36(11):1628-1638. PubMed ID: 27031405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis.
    Silva RL; Santos MB; Almeida PL; Barros TS; Magalhães L; Cazzaniga RA; Souza PR; Luz NF; França-Costa J; Borges VM; Lima-Junior DS; Lipscomb MW; Duthie MS; Reed SG; Almeida RP; Jesus AR
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005486. PubMed ID: 28355218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of soluble TWEAK and CD163 concentrations in patients with chronic heart failure.
    Ptaszynska-Kopczynska K; Marcinkiewicz-Siemion M; Lisowska A; Waszkiewicz E; Witkowski M; Jasiewicz M; Miklasz P; Jakim P; Galar B; Musial WJ; Kaminski KA
    Cytokine; 2016 Apr; 80():7-12. PubMed ID: 26916171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease.
    Rødgaard-Hansen S; St George A; Kazankov K; Bauman A; George J; Grønbæk H; Jon Møller H
    Scand J Clin Lab Invest; 2017 Nov; 77(7):498-504. PubMed ID: 28715286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanisms.
    Nielsen MC; Andersen MN; Rittig N; Rødgaard-Hansen S; Grønbaek H; Moestrup SK; Møller HJ; Etzerodt A
    J Leukoc Biol; 2019 Nov; 106(5):1129-1138. PubMed ID: 31242338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma.
    Kazankov K; Rode A; Simonsen K; Villadsen GE; Nicoll A; Møller HJ; Lim L; Angus P; Kronborg I; Arachchi N; Gorelik A; Liew D; Vilstrup H; Frystyk J; Grønbæk H
    Scand J Clin Lab Invest; 2016; 76(1):64-73. PubMed ID: 26549495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of Dermatophagoides pteronyssinus allergens and dexamethasone on the expression of CD163 by peripheral blood mononuclear cells.
    Bernatowicz PL; Pampuch A; Golec P; Sacharzewska E; Szczesiul M; Bielecki P; Kowal K
    Immunobiology; 2019 Jul; 224(4):497-501. PubMed ID: 31133346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of serum sCD163 in patients with liver diseases and inflammatory disorders.
    Wang J; Yu Y; Yang Y; Wu SS; Zhu HH; Liu YN; Liu WX; Hu Y; Wu W; Xia CX; Chen Z
    Int J Clin Exp Pathol; 2015; 8(7):8419-25. PubMed ID: 26339412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD163 is produced by monocyte-derived and alveolar macrophages, and is not associated with the severity of idiopathic pulmonary fibrosis.
    Chauvin P; Morzadec C; de Latour B; Llamas-Gutierrez F; Luque-Paz D; Jouneau S; Vernhet L
    Innate Immun; 2022 Apr; 28(3-4):138-151. PubMed ID: 35522300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Scavenger Receptor CD163 Is Associated with Severe Acute Kidney Injury in Patients with Hantaan Virus Infection.
    Zhang Y; Ma Y; Zhang C; Zhang Y; Zhuang R; Liu B; Yi J; Jin B
    Viral Immunol; 2015 May; 28(4):241-6. PubMed ID: 25789628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.